184 related articles for article (PubMed ID: 6211752)
1. [Cefoperazone in infections caused by resistant agents, with special reference to Pseudomonas aeruginosa].
Torres A; Vega J; Aguirre M; Alés JM
Rev Clin Esp; 1982 Feb; 164(4):229-32. PubMed ID: 6211752
[No Abstract] [Full Text] [Related]
2. Experimental efficacy and pharmacokinetic properties of cefpiramide, a new cephalosporin.
Fu KP; Vince T; McCloud S; Gregory FJ; Chiang ST; Hung PP
Drugs Exp Clin Res; 1985; 11(11):787-91. PubMed ID: 3939215
[TBL] [Abstract][Full Text] [Related]
3. [Application of a millipore membrane transfer method to the study of the activity of 4 beta-lactams on Pseudomonas aeruginosa].
Denis C; Lesage D; Delisle-Mizon F; Vergez P; Daguet GL
Pathol Biol (Paris); 1984 May; 32(5):415-20. PubMed ID: 6429614
[TBL] [Abstract][Full Text] [Related]
4. A study of cefoperazone alone and in combination with tobramycin against Pseudomonas aeruginosa.
Pavillard ER; Miles H
Clin Ther; 1980; 3(Spec Issue):134-8. PubMed ID: 6446387
[TBL] [Abstract][Full Text] [Related]
5. [Antipseudomonal activities of new cephem antibiotics].
Ohkoshi M
Hinyokika Kiyo; 1984 Apr; 30(4):437-48. PubMed ID: 6435413
[TBL] [Abstract][Full Text] [Related]
6. [Hospital infections caused by Pseudomonas aeruginosa. Significance in intensive therapy].
Sidorenko SV; Gel'fand EB; Mamontova OA
Anesteziol Reanimatol; 1999; (3):46-54. PubMed ID: 10458038
[TBL] [Abstract][Full Text] [Related]
7. [Antibiotic resistance of some Pseudomonas aeruginosa isolates].
Matinca D; Vancea D; Boboş C; Serban O
Bacteriol Virusol Parazitol Epidemiol; 2003; 48(2-3):157-61. PubMed ID: 15341333
[No Abstract] [Full Text] [Related]
8. [In vivo-acquired resistance to cefsulodin by a strain of Pseudomonas aeruginosa].
Jouvenot M; Michel-Briand Y; Dupont MJ; Cattin J
Pathol Biol (Paris); 1984 May; 32(5):426-8. PubMed ID: 6429615
[TBL] [Abstract][Full Text] [Related]
9. [Multiply resistant Pseudomonas aeruginosa in the pediatric field].
Tabuki K
Nihon Rinsho; 1991 Oct; 49(10):2387-92. PubMed ID: 1660948
[No Abstract] [Full Text] [Related]
10. [Trend of therapy in Pseudomonas aeruginosa infections].
Jannuzzi C; Tassara A
G Mal Infett Parassit; 1971 Nov; 23(11):1051-4. PubMed ID: 5004852
[No Abstract] [Full Text] [Related]
11. [Role of antibiotics in infections due to Pseudomonas aeruginosa].
Výmola F; Jedlicková Z
Cesk Epidemiol Mikrobiol Imunol; 1972 Jul; 21(4):176-81. PubMed ID: 4262242
[No Abstract] [Full Text] [Related]
12. Relationship between antibiotic use and incidence of MexXY-OprM overproducers among clinical isolates of Pseudomonas aeruginosa.
Hocquet D; Muller A; Blanc K; Plésiat P; Talon D; Monnet DL; Bertrand X
Antimicrob Agents Chemother; 2008 Mar; 52(3):1173-5. PubMed ID: 18180356
[TBL] [Abstract][Full Text] [Related]
13. [In vitro activity of a new cephalosporin--cefoperazone--against Enterobacteriaceae and Pseudomonas aeruginosa].
Modde H
Schweiz Med Wochenschr; 1981 Mar; 111(10):356-8. PubMed ID: 6452690
[TBL] [Abstract][Full Text] [Related]
14. [Cefoperazone, cefsulodin and ceftazidime--3 cephalosporins active against Pseudomonas in comparison with their monobactam analogs].
Baumgärtner M
Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol; 1983 Apr; 254(2):253-60. PubMed ID: 6326420
[TBL] [Abstract][Full Text] [Related]
15. Ceftolozane/Tazobactam Therapy of Respiratory Infections due to Multidrug-Resistant Pseudomonas aeruginosa.
Gelfand MS; Cleveland KO
Clin Infect Dis; 2015 Sep; 61(5):853-5. PubMed ID: 26021991
[No Abstract] [Full Text] [Related]
16. [Investigation on the antimicrobial activity of cefoperazone (author's transl)].
Primavesi CA
Immun Infekt; 1981 Jul; 9(4):150-3. PubMed ID: 6456219
[TBL] [Abstract][Full Text] [Related]
17. [Drug resistance of bacteria--the current status and future prospect. 5. Pseudomonas aeruginosa].
Nishimura T; Takashima T
Nihon Rinsho; 1984 Mar; 42(3):676-89. PubMed ID: 6433078
[No Abstract] [Full Text] [Related]
18. In vitro evaluation of cefoperazone compared to other antipseudomonal drugs.
Nicoletti P; Mazzei T; Lamanna S
G Batteriol Virol Immunol; 1981; 74(1-6):3-7. PubMed ID: 6458526
[No Abstract] [Full Text] [Related]
19. Comparative in vivo efficacy of meropenem, imipenem, and cefepime against Pseudomonas aeruginosa expressing MexA-MexB-OprM efflux pumps.
Ong CT; Tessier PR; Li C; Nightingale CH; Nicolau DP
Diagn Microbiol Infect Dis; 2007 Feb; 57(2):153-61. PubMed ID: 16930925
[TBL] [Abstract][Full Text] [Related]
20. [Modern aspects of the treatment of Pseudomonas aeruginosa infection].
Rozhavin MA
Antibiotiki; 1980 Apr; 25(4):303-7. PubMed ID: 6768339
[No Abstract] [Full Text] [Related]
[Next] [New Search]
